Hudson Therapeutics Launches Phase 2b Part 2 Trial for NuGel
Hudson Therapeutics Launches Phase 2b Part 2 Trial for NuGel Hudson Therapeutics, the U.S. subsidiary of Shaperon, announced today the initiation of Phase 2b Part 2 of its clinical trial for NuGel, a groundbreaking inflammasome inhibitor aimed at treating mild…
CareDx Expands AlloSure Testing Services with Two New Indications
CareDx Expands AlloSure Testing Services with Two New Indications CareDx, Inc. (Nasdaq: CDNA), known as The Transplant Company™, a leader in precision medicine focused on the discovery, development, and commercialization of advanced healthcare solutions for transplant patients, has announced the…
Strive Health Expands Partnership with Zing Health for Value-Based Kidney Care
Strive Health Expands Partnership with Zing Health for Value-Based Kidney Care Strive Health, a national leader in value-based kidney care, has expanded its partnership with Zing Health, a prominent Medicare Advantage insurer, to provide specialized kidney care to all eligible…
Merck Opens New Facility to Boost Vaccine Production Capacity
Merck Opens New Facility to Boost Vaccine Production Capacity Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has officially opened a new $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina,…
RadiusXR, Glaukos, and Topcon Healthcare Launch Inspire® Visual Field Solution
RadiusXR, Glaukos, and Topcon Healthcare Launch Inspire® Visual Field Solution Topcon Healthcare, RadiusXR, and Glaukos Corporation (NYSE: GKOS) have announced a new collaboration, unveiling RadiusXR’s next-generation wearable vision testing platform, Inspire®. This partnership combines RadiusXR’s innovative visual field technology with…
Greenspace Health Secures Series B Investment from ABS Capital to Innovate Behavioral Health
Greenspace Health Secures Series B Investment from ABS Capital to Innovate Behavioral Health Greenspace Health, a leading provider of SaaS Measurement-Based Care (MBC) technology, has successfully secured a Series B growth equity investment from ABS Capital Partners. This strategic investment…
Pharma Industry Urges Joint Action on Growing Chronic Disease Burden
Pharma Industry Urges Joint Action on Growing Chronic Disease Burden Ahead of a key UN milestone, the global pharmaceutical industry has launched a Call to Action to drive collective efforts in tackling the increasing prevalence of non-communicable diseases (NCDs), such…
LifeStance Names Dave Bourdon CEO, Ken Burdick Executive Chairman
LifeStance Names Dave Bourdon CEO, Ken Burdick Executive Chairman LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental health care, announced today the appointment of Dave Bourdon as the Company’s…
Robert Musslewhite and Sudhakar Ramakrishna Appointed to Cardinal Health Board of Directors
Robert Musslewhite and Sudhakar Ramakrishna Appointed to Cardinal Health Board of Directors Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert Musslewhite and Sudhakar Ramakrishna as independent directors, effective March 7, 2025. Musslewhite, the former…
Noramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectable Manufacturing
Noramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectable Manufacturing The Noramco Group, a North American provider of integrated API and drug product supply chain services, has announced a $25 million investment in its Halo Pharma facility in…
Philips and Ingeborg Initiatives Tackle Maternal Health Challenges in Arkansas via Philips Avent Pregnancy+ App
Philips and Ingeborg Initiatives Tackle Maternal Health Challenges in Arkansas via Philips Avent Pregnancy+ App Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has partnered with Ingeborg Initiatives to offer all expectant parents in Arkansas access…
Care Access Acquires Brazil’s CEMEC Clinical Research Center
Care Access Acquires Brazil’s CEMEC Clinical Research Center Care Access, a global healthcare and research company, has announced the acquisition of Centro Multidisciplinar de Estudos Clínicos (CEMEC), a leading clinical research center in Brazil. This acquisition represents a significant step…